search
tissue engineering
Trends
- 1Muscle-powered paper-thin robot swims through watery maze▼Powered by muscle cells, a paper-thin robot swims through watery maze
MIT researchers have built a paper-thin swimming robot powered by living muscle cells, capable of navigating through watery mazes. The soft robotic swimmer represents progress in biohybrid robotics, where engineered muscle tissue drives tiny machines. Coverage from MIT News and Robohub highlights its potential uses in medicine and microscale tasks.
- 2New 4D biofabrication technology promises advances in tissue engineering▼New 4D biofabrication technology holds promise for tissue engineering, wound healing
Researchers have introduced a new 4D biofabrication technology that could reshape tissue engineering and wound healing. Unlike static 3D-printed structures, the approach allows engineered materials to change shape or function over time in response to their environment. Coverage from University of Illinois Chicago and science outlets highlights its potential to produce dynamic tissues and smarter medical implants, with researchers describing it as an early but promising step toward regenerative medicine applications.
- 3Regenerative biology: how organisms repair and restore damaged tissue▼Regenerative Biology is the study of how organisms repair, replace, or restore damaged or missing cells, tissues, organs
Regenerative biology studies how organisms repair, replace or restore damaged or missing cells, tissues, organs and even entire body parts, returning them to full physiological function. The field draws on cell biology, bioengineering and genetics, and is being highlighted as a key area of modern biological research with implications for medicine and tissue engineering.
- 4Hormone Recipe Speeds Callus Growth in Papaya Tissue Culture▼Hormone Recipe Unlocks Rapid Callus Growth in Papaya Tissue Culture
Researchers have reported a hormone treatment that promotes rapid callus growth in papaya tissue culture, according to a science news report. Callus formation is a key early step in plant propagation and genetic engineering, so a faster, more reliable protocol could help labs working on papaya improvement and disease-resistant varieties.
- 5
Researchers have developed robots powered by lab-grown muscle tissue, using cultivated biological muscle as an actuator instead of conventional motors. The approach suggests a path toward softer, more energy-efficient machines that combine living tissue with engineered skeletons. Coverage in the electronics press highlights the engineering challenge of keeping living muscle alive and responsive inside a machine. It marks another step in biohybrid robotics, where biology and machines are increasingly merged.
- 6
CAR T-cell therapy, already approved for blood cancers, faces major hurdles in solid tumors, where hostile microenvironments suppress engineered immune cells. A new approach reported in pharmaceutical manufacturing coverage aims to build or arm CAR T cells directly inside tumor tissue, potentially improving persistence and reducing off-target effects. Researchers see in-situ engineering as a promising route to finally extend cell therapy beyond blood cancers, though clinical proof remains limited.
- 7Regenerative medicine market forecast to reach $62.69 billion by 2031▼Regenerative Medicine Market worth $62.69 billion by 2031
A new market analysis projects the global regenerative medicine market will be worth $62.69 billion by 2031. The field, which covers stem cell therapies, tissue engineering and cell-based treatments, continues to attract investment as demand grows for treatments that repair rather than manage disease. The forecast is being picked up across healthcare and industry outlets tracking growth in advanced therapies.
- 8Regenerative medicine market projected to reach $62.69 billion by 2031●Regenerative Medicine Market worth $62.69 billion by 2031 - Exclusive Report by MarketsandMarkets™
A new MarketsandMarkets report forecasts the global regenerative medicine market will be worth $62.69 billion by 2031. The projection highlights growing investment in stem cell therapies, tissue engineering and cell-based treatments as demand rises for alternatives to conventional medicine. Industry watchers see the sector as one of the fastest-growing areas in healthcare over the coming decade.